Philadelphia biotech firm teams up with CHOP & Penn to battle lung cancer
The partners are collaborating to advance a new approach to cancer immunotherapy that uses next-generation RNA silencing technology.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: John George Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Health Management | Immunotherapy | Lung Cancer